Thats definitely the current approach. IMO IMU could be game changing if and when it works but are only pre clinical for OnCARlytics thus far. In human can be a different ball game and still has to be proven in many cancer types which will take even longer with basket trials etc. In the meantime specific targets are the way forward.
CHM Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)